ID VIP1_YEAST Reviewed; 1146 AA. AC Q06685; D6VZ44; DT 09-JAN-2007, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 27-MAR-2024, entry version 168. DE RecName: Full=Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase {ECO:0000305}; DE EC=2.7.4.24 {ECO:0000269|PubMed:17412958}; DE AltName: Full=InsP6 and PP-IP5 kinase; GN Name=VIP1 {ECO:0000312|SGD:S000004402}; OrderedLocusNames=YLR410W; OS Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast). OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes; OC Saccharomycetales; Saccharomycetaceae; Saccharomyces. OX NCBI_TaxID=559292; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=ATCC 204508 / S288c; RX PubMed=9169871; RA Johnston M., Hillier L.W., Riles L., Albermann K., Andre B., Ansorge W., RA Benes V., Brueckner M., Delius H., Dubois E., Duesterhoeft A., RA Entian K.-D., Floeth M., Goffeau A., Hebling U., Heumann K., RA Heuss-Neitzel D., Hilbert H., Hilger F., Kleine K., Koetter P., Louis E.J., RA Messenguy F., Mewes H.-W., Miosga T., Moestl D., Mueller-Auer S., RA Nentwich U., Obermaier B., Piravandi E., Pohl T.M., Portetelle D., RA Purnelle B., Rechmann S., Rieger M., Rinke M., Rose M., Scharfe M., RA Scherens B., Scholler P., Schwager C., Schwarz S., Underwood A.P., RA Urrestarazu L.A., Vandenbol M., Verhasselt P., Vierendeels F., Voet M., RA Volckaert G., Voss H., Wambutt R., Wedler E., Wedler H., Zimmermann F.K., RA Zollner A., Hani J., Hoheisel J.D.; RT "The nucleotide sequence of Saccharomyces cerevisiae chromosome XII."; RL Nature 387:87-90(1997). RN [2] RP GENOME REANNOTATION. RC STRAIN=ATCC 204508 / S288c; RX PubMed=24374639; DOI=10.1534/g3.113.008995; RA Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R., RA Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S., RA Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.; RT "The reference genome sequence of Saccharomyces cerevisiae: Then and now."; RL G3 (Bethesda) 4:389-398(2014). RN [3] RP FUNCTION. RX PubMed=10388810; DOI=10.1093/genetics/152.3.895; RA Feoktistova A., McCollum D., Ohi R., Gould K.L.; RT "Identification and characterization of Schizosaccharomyces pombe asp1(+), RT a gene that interacts with mutations in the Arp2/3 complex and actin."; RL Genetics 152:895-908(1999). RN [4] RP SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]. RX PubMed=14562095; DOI=10.1038/nature02026; RA Huh W.-K., Falvo J.V., Gerke L.C., Carroll A.S., Howson R.W., RA Weissman J.S., O'Shea E.K.; RT "Global analysis of protein localization in budding yeast."; RL Nature 425:686-691(2003). RN [5] RP LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS]. RX PubMed=14562106; DOI=10.1038/nature02046; RA Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N., RA O'Shea E.K., Weissman J.S.; RT "Global analysis of protein expression in yeast."; RL Nature 425:737-741(2003). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC STRAIN=YAL6B; RX PubMed=15665377; DOI=10.1074/mcp.m400219-mcp200; RA Gruhler A., Olsen J.V., Mohammed S., Mortensen P., Faergeman N.J., Mann M., RA Jensen O.N.; RT "Quantitative phosphoproteomics applied to the yeast pheromone signaling RT pathway."; RL Mol. Cell. Proteomics 4:310-327(2005). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-54, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC STRAIN=ADR376; RX PubMed=17330950; DOI=10.1021/pr060559j; RA Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J., RA Elias J.E., Gygi S.P.; RT "Large-scale phosphorylation analysis of alpha-factor-arrested RT Saccharomyces cerevisiae."; RL J. Proteome Res. 6:1190-1197(2007). RN [8] RP FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-487 AND HIS-548. RX PubMed=17412958; DOI=10.1126/science.1139099; RA Mulugu S., Bai W., Fridy P.C., Bastidas R.J., Otto J.C., Dollins D.E., RA Haystead T.A., Ribeiro A.A., York J.D.; RT "A conserved family of enzymes that phosphorylate inositol RT hexakisphosphate."; RL Science 316:106-109(2007). RN [9] RP FUNCTION. RX PubMed=17412959; DOI=10.1126/science.1139080; RA Lee Y.-S., Mulugu S., York J.D., O'Shea E.K.; RT "Regulation of a cyclin-CDK-CDK inhibitor complex by inositol RT pyrophosphates."; RL Science 316:109-112(2007). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31 AND SER-77, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200; RA Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.; RT "A multidimensional chromatography technology for in-depth phosphoproteome RT analysis."; RL Mol. Cell. Proteomics 7:1389-1396(2008). RN [11] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31; SER-895 AND SER-1107, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=19779198; DOI=10.1126/science.1172867; RA Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.; RT "Global analysis of Cdk1 substrate phosphorylation sites provides insights RT into evolution."; RL Science 325:1682-1686(2009). CC -!- FUNCTION: Bifunctional inositol kinase that acts in concert with the CC IP6K kinases to synthesize the diphosphate group-containing inositol CC pyrophosphates diphosphoinositol pentakisphosphate, PP-InsP5, and bis- CC diphosphoinositol tetrakisphosphate, (PP)2-InsP4 (PubMed:17412958). CC Phosphorylates inositol hexakisphosphate (InsP6) at position 1 to CC produce PP-InsP5 which is in turn phosphorylated by IP6Ks to produce CC (PP)2-InsP4. Alternatively, phosphorylates PP-InsP5 at position 1, CC produced by IP6Ks from InsP6, to produce (PP)2-InsP4 (By similarity). CC Required for maintaining cellular integrity, normal growth and CC interactions with the ARP complex (PubMed:10388810). Acts as a CC regulator of the PHO80-PHO85 cyclin/cyclin-dependent kinase (CDK) CC complex, thereby regulating signaling of phosphate availability CC (PubMed:17412959). Required for the function of the cortical actin CC cytoskeleton, possibly by participating in correct F-actin localization CC and ensuring polarized growth (PubMed:10388810). Regulates polarized CC growth and modulates interphase microtubule cytoskeleton. Regulates CC microtubule dynamics without the requirement of microtubule plus-end CC tracking protein Mal3. Required for growth zone selection (By CC similarity). {ECO:0000250|UniProtKB:O74429, CC ECO:0000250|UniProtKB:Q6PFW1, ECO:0000269|PubMed:10388810, CC ECO:0000269|PubMed:17412958, ECO:0000269|PubMed:17412959}. CC -!- CATALYTIC ACTIVITY: CC Reaction=1D-myo-inositol hexakisphosphate + ATP = 1-diphospho-1D-myo- CC inositol 2,3,4,5,6-pentakisphosphate + ADP; Xref=Rhea:RHEA:37459, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:58130, ChEBI:CHEBI:74946, CC ChEBI:CHEBI:456216; EC=2.7.4.24; CC Evidence={ECO:0000269|PubMed:17412958}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:37460; CC Evidence={ECO:0000305|PubMed:17412958}; CC -!- CATALYTIC ACTIVITY: CC Reaction=5-diphospho-1D-myo-inositol 1,2,3,4,6-pentakisphosphate + ATP CC + H(+) = 1,5-bis(diphospho)-1D-myo-inositol 2,3,4,6-tetrakisphosphate CC + ADP; Xref=Rhea:RHEA:10276, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, CC ChEBI:CHEBI:58628, ChEBI:CHEBI:77983, ChEBI:CHEBI:456216; CC EC=2.7.4.24; Evidence={ECO:0000269|PubMed:17412958}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10277; CC Evidence={ECO:0000305|PubMed:17412958}; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:14562095}. CC Cytoplasm, cytoskeleton {ECO:0000269|PubMed:14562095}. CC -!- DOMAIN: The N-terminal kinase domain produces inositol polyphosphates. CC The C-terminal acid phosphatase-like domain binds inositol CC polyphosphates and negatively regulates their accumulation. The C- CC terminal domain reduces the amount of inositol pyrophosphates in a CC dose-dependent manner in vitro. {ECO:0000250|UniProtKB:O74429}. CC -!- MISCELLANEOUS: Present with 8810 molecules/cell in log phase SD medium. CC {ECO:0000269|PubMed:14562106}. CC -!- SIMILARITY: Belongs to the histidine acid phosphatase family. VIP1 CC subfamily. {ECO:0000305}. CC -!- CAUTION: Although related to histidine acid phosphatase proteins, it CC lacks the conserved active sites, suggesting that it has no phosphatase CC activity. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U20162; AAB67497.1; -; Genomic_DNA. DR EMBL; BK006945; DAA09710.1; -; Genomic_DNA. DR PIR; S59376; S59376. DR RefSeq; NP_013514.1; NM_001182298.1. DR AlphaFoldDB; Q06685; -. DR SMR; Q06685; -. DR BioGRID; 31667; 560. DR IntAct; Q06685; 31. DR MINT; Q06685; -. DR STRING; 4932.YLR410W; -. DR GlyGen; Q06685; 7 sites, 1 O-linked glycan (7 sites). DR iPTMnet; Q06685; -. DR MaxQB; Q06685; -. DR PaxDb; 4932-YLR410W; -. DR PeptideAtlas; Q06685; -. DR EnsemblFungi; YLR410W_mRNA; YLR410W; YLR410W. DR GeneID; 851126; -. DR KEGG; sce:YLR410W; -. DR AGR; SGD:S000004402; -. DR SGD; S000004402; VIP1. DR VEuPathDB; FungiDB:YLR410W; -. DR eggNOG; KOG1057; Eukaryota. DR GeneTree; ENSGT00390000009048; -. DR HOGENOM; CLU_000914_3_1_1; -. DR InParanoid; Q06685; -. DR OMA; IQERWCC; -. DR OrthoDB; 5476261at2759; -. DR BioCyc; YEAST:MONOMER3O-224; -. DR Reactome; R-SCE-1855167; Synthesis of pyrophosphates in the cytosol. DR BioGRID-ORCS; 851126; 0 hits in 10 CRISPR screens. DR PRO; PR:Q06685; -. DR Proteomes; UP000002311; Chromosome XII. DR RNAct; Q06685; Protein. DR GO; GO:0005737; C:cytoplasm; HDA:SGD. DR GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell. DR GO; GO:0005829; C:cytosol; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; ISS:UniProtKB. DR GO; GO:0033857; F:diphosphoinositol-pentakisphosphate kinase activity; IBA:GO_Central. DR GO; GO:0000829; F:inositol heptakisphosphate kinase activity; IDA:SGD. DR GO; GO:0052723; F:inositol hexakisphosphate 1-kinase activity; IDA:SGD. DR GO; GO:0052724; F:inositol hexakisphosphate 3-kinase activity; IDA:SGD. DR GO; GO:0000830; F:inositol hexakisphosphate 4-kinase activity; IDA:SGD. DR GO; GO:0000832; F:inositol hexakisphosphate 5-kinase activity; IEA:UniProtKB-EC. DR GO; GO:0000831; F:inositol hexakisphosphate 6-kinase activity; IDA:SGD. DR GO; GO:0000828; F:inositol hexakisphosphate kinase activity; IBA:GO_Central. DR GO; GO:0000827; F:inositol-1,3,4,5,6-pentakisphosphate kinase activity; IEA:UniProtKB-EC. DR GO; GO:0052843; F:inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity; IDA:SGD. DR GO; GO:0052845; F:inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity; IDA:SGD. DR GO; GO:0006020; P:inositol metabolic process; IBA:GO_Central. DR GO; GO:0032958; P:inositol phosphate biosynthetic process; IDA:SGD. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR GO; GO:0051516; P:regulation of bipolar cell growth; ISS:UniProtKB. DR GO; GO:0070507; P:regulation of microtubule cytoskeleton organization; ISS:UniProtKB. DR CDD; cd07061; HP_HAP_like; 1. DR Gene3D; 3.40.50.11950; -; 1. DR Gene3D; 3.30.470.20; ATP-grasp fold, B domain; 1. DR Gene3D; 3.40.50.1240; Phosphoglycerate mutase-like; 1. DR InterPro; IPR013651; ATP-grasp_RimK-type. DR InterPro; IPR000560; His_Pase_clade-2. DR InterPro; IPR037446; His_Pase_VIP1. DR InterPro; IPR029033; His_PPase_superfam. DR InterPro; IPR040557; VIP1_N. DR PANTHER; PTHR12750; DIPHOSPHOINOSITOL PENTAKISPHOSPHATE KINASE; 1. DR PANTHER; PTHR12750:SF9; INOSITOL HEXAKISPHOSPHATE AND DIPHOSPHOINOSITOL-PENTAKISPHOSPHATE KINASE; 1. DR Pfam; PF00328; His_Phos_2; 1. DR Pfam; PF18086; PPIP5K2_N; 1. DR Pfam; PF08443; RimK; 1. DR SUPFAM; SSF56059; Glutathione synthetase ATP-binding domain-like; 1. DR SUPFAM; SSF53254; Phosphoglycerate mutase-like; 1. PE 1: Evidence at protein level; KW ATP-binding; Cytoplasm; Cytoskeleton; Kinase; Nucleotide-binding; KW Phosphoprotein; Reference proteome; Transferase. FT CHAIN 1..1146 FT /note="Inositol hexakisphosphate and diphosphoinositol- FT pentakisphosphate kinase" FT /id="PRO_0000270924" FT REGION 1..33 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 93..185 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 530..597 FT /note="Polyphosphoinositide-binding domain" FT /evidence="ECO:0000250|UniProtKB:Q6PFW1" FT REGION 1106..1146 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 15..33 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 93..111 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 121..178 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 1128..1146 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 197..198 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 278 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 351 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 358 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 377..378 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 377 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 402..405 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 412..414 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 414 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 428 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 430 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 475 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 487..489 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250|UniProtKB:O43314" FT BINDING 492..495 FT /ligand="substrate" FT /evidence="ECO:0000250|UniProtKB:O43314" FT MOD_RES 31 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956, FT ECO:0007744|PubMed:19779198" FT MOD_RES 54 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17330950" FT MOD_RES 77 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18407956" FT MOD_RES 895 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:19779198" FT MOD_RES 1107 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:19779198" FT MUTAGEN 487 FT /note="D->A: Abolishes enzyme activity." FT /evidence="ECO:0000269|PubMed:17412958" FT MUTAGEN 548 FT /note="H->A: Does not affect enzyme activity." FT /evidence="ECO:0000269|PubMed:17412958" SQ SEQUENCE 1146 AA; 129755 MW; D69E44EAD16490F9 CRC64; MSGIKKEPIE SDEVPQQETK NNLPSAPSEM SPLFLNKNTQ KAMQSIAPIL EGFSPKTSAS ENMSLKLPPP GIQDDHSEEN LTVHDTLQRT ISTALGNGNN TNTVTTSGLK KADSESKSEA DPEGLSNSNI VNDADNINSI SKTGSPHLPQ GTMDAEQTNM GTNSVPTSSA SSRKSSTSHP KPRLPKVGKI GVCAMDAKVL SKPMRHILNR LIEHGEFETV IFGDKVILDE RIENWPTCDF LISFFSSGFP LDKAIKYVKL RKPFIINDLI MQKILWDRRL CLQVLEAYNV PTPPRLEISR DGGPRANEEL RAKLREHGVE VKPVEEPEWK MVDDDTLEVD GKTMTKPFVE KPVDGEDHNI YIYYHSKNGG GGRRLFRKVG NKSSEFDPTL VHPRTEGSYI YEQFMDTDNF EDVKAYTIGE NFCHAETRKS PVVDGIVRRN THGKEVRYIT ELSDEEKTIA GKVSKAFSQM ICGFDLLRVS GKSYVIDVNG FSFVKDNKAY YDSCANILRS TFIEAKKKMD MEKKNLPIIR EEKEQKWVFK GLAIIIRHAD RTPKQKFKHS FTSPIFISLL KGHKEEVVIR NVNDLKIVLQ ALRIALDEKA GNPAKIKVLA NALEKKLNFP GTKIQLKPVL NKENEVEKVQ FILKWGGEPT HSAKYQATEL GEQMRQDFDL LNKSILQNIK IFSSSERRVL HTAQYWTRAL FGADELGSDE ISIRKDLLDD SNAAKDLMDK VKKKLKPLLR EGKEAPPQFA WPSKMPEPYL VIKRVVELMN YHKKIMDNNF AKKDVNSMQT RWCTSEDPSL FKERWDKLFK EFNNAEKVDP SKISELYDTM KYDALHNRQF LENIFDPGLP NEAIADELGS HSLVDRYPIN VLAKNNFKII DSHSMNNSGK NSSNSVGSLG WVLESGKTST ARNPKSSSQF DEPRFMQLRE LYKLAKVLFD FICPKEYGIS DAEKLDIGLL TSLPLAKQIL NDIGDMKNRE TPACVAYFTK ESHIYTLLNI IYESGIPMRI ARNALPELDY LSQITFELYE STDASGQKSH SIRLKMSPGC HTQDPLDVQL DDRHYISCIP KISLTKHLDM DYVQQKLRNK FTRVIMPPKF TPVNITSPNL SFQKRKTRRK SVSVEKLKRP ASSGSSSSTS VNKTLD //